Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management (Q36791755)

16 August 2017

1 reference

title

Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management (English)

1 reference

16 August 2017

1 reference

Melanie S M van Breemen

series ordinal

1

1 reference

16 August 2017

Erik B Wilms

series ordinal

2

1 reference

16 August 2017

Charles J Vecht

series ordinal

3

1 reference

16 August 2017

publication date

1 May 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

6

1 reference

16 August 2017

issue

5

1 reference

16 August 2017

page(s)

421-430

1 reference

Neurocognitive sequelae in the treatment of low-grade gliomas

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Interactions between antiepileptic and chemotherapeutic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Epilepsy after brain insult: targeting epileptogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Medical management of patients with brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Epilepsy in patients with central nervous system tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Epilepsy and brain tumors: implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Brain tumoral epilepsy: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Management of epileptic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

The course of seizure disorders in patients with malignant gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Intracranial meningiomas and epilepsy: incidence, prognosis and influencing factors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Seizure prophylaxis in patients with brain tumors: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Influences of brain tumor-associated pH changes and hypoxia on epileptogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Perilesional neurochemical changes in focal epilepsies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Magnetoencephalography (MEG) predicts focal epileptogenicity in cavernomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

The pathogenesis of tumour associated epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

No evidence for a seriously increased malignancy risk in LGI1-caused epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Mirror focus: function of seizure frequency and influence on outcome after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

The role of anticonvulsant medications in the management of patients with anaplastic gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Phenytoin and postoperative epilepsy. A double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Should prophylactic anticonvulsants be administered to patients with newly-diagnosed cerebral metastases? A retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Add-on phenytoin fails to prevent early seizures after surgery for supratentorial brain tumors: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Epileptic seizures during follow-up of patients treated for primary brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Levetiracetam: preliminary experience in patients with primary brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Add-on gabapentin for refractory seizures in patients with brain tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Levetiracetam therapy in patients with brain tumour and epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Patients with refractory seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Genetics of drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Role of multidrug transporters in pharmacoresistance to antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Role of drug efflux carriers in the healthy and diseased brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Does P-glycoprotein play a role in pharmacoresistance to antiepileptic drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Multidrug resistance transporters and modulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Pharmacoresistance and expression of multidrug transporter P-glycoprotein in kindled rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Multidrug resistance: can new drugs help chemotherapy score against cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Low-grade glial neoplasms and intractable partial epilepsy: efficacy of surgical treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Surgical treatment of refractory epilepsy associated with space occupying lesions. Experience and review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Surgical treatment of neoplasms associated with medically intractable epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Seizure recurrence and risk factors after antiepilepsy drug withdrawal in children with brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Gamma Knife Radiosurgery for Refractory Epilepsy Caused by Hypothalamic Hamartomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Effect of cranial irradiation on seizure frequency in adults with low-grade astrocytoma and medically intractable epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Effect of ionizing radiation on partial seizures attributable to malignant cerebral tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

First-line nitrosourea-based chemotherapy in symptomatic non-resectable supratentorial pure low-grade astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Initial treatment of epilepsy: special issues in treating the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Pharmacological and clinical aspects of antiepileptic drug use in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Increased risk of erythema multiforme major with combination anticonvulsant and radiation therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Serum anticonvulsant concentrations and the risk of drug induced skin eruptions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Stevens-Johnson syndrome and epidermal necrolysis after administration of sodium phenytoin with cranial irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Influence of phenytoin on the disposition of irinotecan: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants. NABTT CNS Consortium. The New Approaches to Brain Tumor Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

An interaction between cytostatic and anticonvulsant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Phenytoin and fluorouracil interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Oral tegafur/folinic acid chemotherapy decreases phenytoin efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Treatment of epilepsy in adults: expert opinion, 2005.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Carbamazepine versus valproate monotherapy for epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Hematologic toxicity of sodium valproate

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Valproate-associated coagulopathies are frequent and variable in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Preoperative valproate administration does not increase blood loss during temporal lobectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Absence of bleeding complications in patients undergoing cortical surgery while receiving valproate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

The activity of antiepileptic drugs as histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

The 'number needed to treat' with Levetiracetam (LEV): comparison with the other new antiepileptic drugs (AEDs).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

Inhibition of multidrug transporters by verapamil or probenecid does not alter blood-brain barrier penetration of levetiracetam in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970103-5

7 January 2021

10.1016/S1474-4422(07)70103-5

Identifiers

DOI

1 reference

16 August 2017

1 reference